$0.66

0.01 (1.50%)

Buy
below
Hold
up to
Sell
above
Buy Hold Sell Meter
Locked Recommendation

Analysis

Overview

Current recommendation
Business risk 0
Share price risk 0

General Information

Starpharma Holdings Limited
SPL
http://www.starpharma.com
Pharmaceuticals
240
367

Current Price Data+

Current Price $0.655
Open $0.655
High $0.655
Low $0.640
Last Close $0.665
Volume 90998
Price Movement $0.01 ( 1.50% )
  • +Security prices are delayed by least 20 minutes and are indicative only.

Stock Price

Current Broker Consensus Recommendation

Buy
2 May 2016
1

Company Overview

Business Description

Starpharma Holdings Limited (SPL) is a biotechnology company that engages in the development of dendrimer products for pharmaceutical, life science and other applications. SPL's underlying technology is built around dendrimers, a type of synthetic nanoscale polymer that is highly regular in size and structure and well suited to pharmaceutical uses. SPL has three core development programs: VivaGel portfolio, drug delivery, and agrochemicals.

Financial Summary

Year to Jun NPAT EPS EPS chg (%) PER DPS Yield (%) Franking (%)
2017 F 0.0 3.4 0.0% 19.3 0.0 0.0% 0.0%
2016 F 0.0 -6.4 0.0% 0.0 0.0 0.0% 0.0%
2015 A -19.0 -6.1 0.0% 0.0 0.0 0.0% 0.0%

Peer Comparison

Company Mkt Cap EPS Growth (%) P/E (%) Dividend Yield (%)
2015 A 2016 F 2017 F 2015 A 2016 F 2017 F 2015 A 2016 F 2017 F
Mayne Pharma Group (MYX) $1,138M -0.3897 2.1675 0.1008 73.5602 23.2231 21.0961 0.00% 0.00% 0.00%
Starpharma (SPL) $244M 0.0000 0.0000 0.0000 0.0000 0.0000 19.5588 0.00% 0.00% 0.00%

Financial Summary

Earnings P/E Ratio P/B Ratio P/E Growth
Company 0.36 0.00 5.56 0.00
Market 1.04 16.30 1.29 1.53
Sector 0.49 15.70 3.30 0.71

Directors

Name Position Start Date
Dr Jacinth (Jackie) Kincaid Fairley Chief Executive Officer, Executive Director 1 Jul 2006
Ms Zita Peach Non-Executive Director 1 Oct 2011
Mr Peter R Turvey Non-Executive Director 19 Mar 2012
Mr Richard A Hazelton Non-Executive Director 1 Dec 2006
Mr Robert Bain Thomas Non-Executive Director, Non-Executive Chairman 4 Dec 2013

Management

Name Position
Nigel Baade Chief Financial Officer,Company Secretary
A Eglezos VP, Business Development
C P Barrett VP, Business Development
J R Paull VP, Development & Regulatory Affairs
D J Owen VP, Research

Substantial Shareholders

Holding Name
47,381,272 (14.85%) Allan Gray Australia Pty Ltd
37,069,789 (13.06%) M&G Investment Funds
19,654,406 (6.16%) FIL Limited

Calendar of Events

Date Event
15 February 2017 Report (Interim)
19 August 2016 Report (Prelim)
19 August 2016 Report (Annual)
© 2011 Morningstar, Inc. All rights reserved. The data and content contained herein are not guaranteed to be accurate, complete or timely. Neither Morningstar, nor its affiliates nor their content providers will have any liability for use or distribution of any of this information. To the extent that any of the content above constitutes advice, it is general advice that has been prepared by Morningstar Australasia Pty Ltd ABN: 95 090 665 544, AFSL: 240892 (a subsidiary of Morningstar, Inc.), without reference to your objectives, financial situation or needs. Before acting on any advice, you should consider the appropriateness of the advice and we recommend you obtain financial, legal and taxation advice before making any financial investment decision. If applicable investors should obtain the relevant product disclosure statement and consider it before making any decision to invest. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). DISCLOSURE: Employees may have an interest in the securities discussed in this report. Please refer to our Financial Services Guide (FSG) for more information at www.morningstar.com.au/fsg.asp.